Employers have limited levers to manage specialty drug costs under the Rx plan

  • Rising costs

    Cost of current medications are continually rising

  • Expanding indications

    After initial launch, expanding indications can lead to more eligible patients

  • Limited innovation

    Modest evolution in drug pricing

Today's reality: Unsustainable trends for clients and members

50%

Half of Rx plan spend is specialty and is growing

$133B

50 – 55 new specialty drugs driving an additional $133B in the next 5 years

This chart is unable to display due to Privacy Settings.
The chart could not be loaded because the Privacy Settings are disabled. Under the "Manage Cookies" option in the footer, accept the “Functional cookies” and refresh the page to allow the chart to display.

Imagine an innovative model that can offer:

    Let's get started

    Tell us your needs and our specialists will guide you down the right path.